| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/07/2001 | CA2121199C Ether derivatives |
| 08/07/2001 | CA2104782C 1-substituted, 2-substituted 1h-imidazo-[4,5-c]quinolin-4- amines |
| 08/07/2001 | CA2092919C Epoxysuccinamic acid derivatives |
| 08/07/2001 | CA2085345C Pyrimidine nucleoside derivatives |
| 08/07/2001 | CA2069055C Process for preparing intermediates to nizatidine and related compounds |
| 08/07/2001 | CA2051659C Platelet membrane microparticles |
| 08/07/2001 | CA2045883C Process for the extrusion preparation of actives granules |
| 08/07/2001 | CA2015296C Pyranyl cyanoguanidine derivatives |
| 08/07/2001 | CA1341281C Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen |
| 08/04/2001 | CA2298041A1 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 08/03/2001 | CA2334066A1 A non-arrhythmogenic metabolite of oxybutynin |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055370A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 08/02/2001 | WO2001055357A2 Myeloid colony stimulating factor and uses thereof |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055221A1 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 08/02/2001 | WO2001055210A2 Human cyr61 |
| 08/02/2001 | WO2001055182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
| 08/02/2001 | WO2001055158A1 Azalide antibiotic compositions |
| 08/02/2001 | WO2001055153A1 Clavams as protease inhibitors |
| 08/02/2001 | WO2001055152A1 BENZOXATHIEPINO[3,4-b]PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 08/02/2001 | WO2001055150A1 4-heteroaryl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof |
| 08/02/2001 | WO2001055149A1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 08/02/2001 | WO2001055148A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 08/02/2001 | WO2001055147A1 PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS |
| 08/02/2001 | WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 08/02/2001 | WO2001055134A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 08/02/2001 | WO2001055132A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 08/02/2001 | WO2001055131A2 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 08/02/2001 | WO2001055128A1 Formulation for protection against oxidative stress containing benzofuranone derivatives |
| 08/02/2001 | WO2001055126A2 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii |
| 08/02/2001 | WO2001055123A1 Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient |
| 08/02/2001 | WO2001055122A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 08/02/2001 | WO2001055121A1 Azepine derivatives |
| 08/02/2001 | WO2001055120A1 Preparation of sulfonamides |
| 08/02/2001 | WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/02/2001 | WO2001055116A2 Quinoline derivatives and their use as aurora 2 kinase inhibitors |
| 08/02/2001 | WO2001055115A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | WO2001055114A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 08/02/2001 | WO2001055112A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | WO2001055110A1 Isatine derivatives with neurotrophic activity |
| 08/02/2001 | WO2001055108A2 Use of spl a2 inhibitors for the treatment of inflammation |
| 08/02/2001 | WO2001055106A2 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | WO2001055105A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
| 08/02/2001 | WO2001055101A2 A new process for the preparation of latanoprost |
| 08/02/2001 | WO2001055100A1 Isolation of carotenoid crystals |
| 08/02/2001 | WO2001055098A1 Palatable arginine compounds and uses thereof for cardiovascular health |
| 08/02/2001 | WO2001055097A1 Preparation of nitrogen mustard derivatives |
| 08/02/2001 | WO2001055094A1 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate |
| 08/02/2001 | WO2001055093A1 N-arylhydrazide compounds and use thereof as drugs |
| 08/02/2001 | WO2001055092A2 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 08/02/2001 | WO2001055086A1 Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
| 08/02/2001 | WO2001055085A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity |
| 08/02/2001 | WO2001055083A1 Inositol derivatives and their pharmaceutical use |
| 08/02/2001 | WO2001055082A2 Intermediates for biologically active compounds |
| 08/02/2001 | WO2001055078A1 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
| 08/02/2001 | WO2001054771A2 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054748A1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
| 08/02/2001 | WO2001054742A1 A medicinal aerosol formulation |
| 08/02/2001 | WO2001054741A1 A medicinal aerosol formulation |
| 08/02/2001 | WO2001054736A2 Compositions treated to inactivate infectious proteins |
| 08/02/2001 | WO2001054731A2 Ligand conjugates and methods for preparing same |
| 08/02/2001 | WO2001054730A1 METHOD FOR PRODUCING A COENZYME Q10 / η-CYCLODEXTRIN COMPLEX |
| 08/02/2001 | WO2001054729A1 Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors |
| 08/02/2001 | WO2001054728A1 NOVEL REMEDIES WITH THE USE OF β3 AGONIST |
| 08/02/2001 | WO2001054726A1 REMEDIES FOR REPERFUSION INJURY CONTAINING INTEGRIN αvβ3 ANTAGONIST |
| 08/02/2001 | WO2001054724A1 Anticancer compositions |
| 08/02/2001 | WO2001054710A1 Auxiliary agents for ophthalmic operation |
| 08/02/2001 | WO2001054707A2 Modification of surface proteins by aminopeptidase inhibitors |
| 08/02/2001 | WO2001054705A1 Cancer cell implantation inhibitors |
| 08/02/2001 | WO2001054702A1 Novel compounds |
| 08/02/2001 | WO2001054700A1 Pharmaceutical preparation and method for treatment of diabetes |
| 08/02/2001 | WO2001054699A1 Selective estrogen receptor modulators in combination with estrogens |
| 08/02/2001 | WO2001054698A1 Method for preventing or treating postoperative ileus |
| 08/02/2001 | WO2001054697A1 Herbal supplement for cognitive related impairment due to estrogen loss |
| 08/02/2001 | WO2001054696A1 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 08/02/2001 | WO2001054695A1 Triazines as appetite suppressor |
| 08/02/2001 | WO2001054694A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | WO2001054693A1 Use of thiostrepton as an anti-mycobacterial agent |
| 08/02/2001 | WO2001054692A1 Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections |
| 08/02/2001 | WO2001054691A1 Nitrate salts of antimicrobial agents |
| 08/02/2001 | WO2001054690A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses |
| 08/02/2001 | WO2001054689A1 Laulimalide compounds as microtubule stabilizing agents |
| 08/02/2001 | WO2001054688A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/02/2001 | WO2001054687A1 Ophthalmic anti-allergy compositions suitable for use with contact lenses |
| 08/02/2001 | WO2001054686A2 L-arginine in combination with other compounds for treating cardiovascular diseases |
| 08/02/2001 | WO2001054685A1 Mucin synthesis inhibitors |
| 08/02/2001 | WO2001054684A1 Eye drops |
| 08/02/2001 | WO2001054683A1 Ibuprofen containing active agent preparation |
| 08/02/2001 | WO2001054682A1 Remedies |
| 08/02/2001 | WO2001054681A2 Composition for treatment of stress |
| 08/02/2001 | WO2001054680A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054679A2 Transdermal composition containing an anesthetic and a vasodilator agent |
| 08/02/2001 | WO2001054678A2 Combination therapy for cancer |
| 08/02/2001 | WO2001054677A2 Ace inhibitor-vasopressin antagonist combinations |
| 08/02/2001 | WO2001054676A2 Formulations for states of dehydration |
| 08/02/2001 | WO2001054675A2 Pharmaceutical compositions comprising terbinafine |
| 08/02/2001 | WO2001054669A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |